LDE225 Diphosphate Catalog No.:M9943-10 Wilderness Environ Med

Wilderness Environ Med

PubMed Central PMCID: PMC3901569

8(3):e60827

Available data also suggest that prophylactic administration of mizolastine is significantly more effective than placebo and as effective as prophylactic terfenadine in delaying the onset of symptoms of seasonal allergic rhinitis

LDE225 Diphosphate Catalog No.:M9943-10 Wilderness Environ MedSonidegib, also known as, erismodegib, LDE225, NVP LDE225, is an orally bioavailable small molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Erismodegib selectively binds to the Hedgehog (Hh) ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. It was approved by the FDA for treating basal cell